scispace - formally typeset
R

Richard N. Clayton

Researcher at Keele University

Publications -  118
Citations -  8946

Richard N. Clayton is an academic researcher from Keele University. The author has contributed to research in topics: Loss of heterozygosity & Adenoma. The author has an hindex of 52, co-authored 116 publications receiving 8544 citations. Previous affiliations of Richard N. Clayton include Diabetes Australia & University Hospitals of North Midlands NHS Trust.

Papers
More filters
Journal ArticleDOI

A paradigm shift in the monitoring of patients with acromegaly: last available growth hormone may overestimate risk.

TL;DR: This study again highlights the limitations of IGF-I in predicting mortality and compared the last available GH/IGF-I analysis to a "time-dependent" and cumulative method during follow-up to assess risk of mortality in the West Midlands Acromegaly study.
Journal ArticleDOI

Does growth hormone releasing factor desensitize the somatotroph? Interpretation of responses of growth hormone during and after 10-hour infusion of GRF 1-29 amide in man.

TL;DR: Following 10‐GRF infusion, responses to bolus injection of GRF were reduced, but variable; in two subjects a small rise in GH levels occurred and in the other two subjects, GH levels fell but in these the GRF bolus had coincided with a GH peak.
Journal ArticleDOI

Monitoring disease activity using GH and IGF‐I in the follow‐up of 501 patients with acromegaly

TL;DR: The aims of treatment in patients with acromegaly are to achieve serum GH/IGF‐I concentrations associated with cure or normalization of mortality and alleviation of symptoms.
Journal ArticleDOI

Altered composition of high density lipoproteins in women with the polycystic ovary syndrome

TL;DR: In this paper, a detailed exploratory study of HDL composition in 35 obese [body mass index (BMI), > 27] and 22 nonobese subjects with polycystic ovary syndrome (PCOS) was conducted in 14 healthy obese and 18 non-obese women.
Journal ArticleDOI

Clinical and genetic changes in a case of a Cushing's carcinoma

TL;DR: Molecular genetic analysis of tumour and metastatic tissue revealed loss of heterozygosity at loci on the autosomes 1p, 3p, 10q26,11q13 and 22q12, and tissue taken at surgery In 1986 also revealed positive cytoplasmic Immunostalning for p53 protein.